Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety

Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety

US Patent 11920139 · Granted Mar 5, 2024

Estimated economic value: $54,955,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Phosphorylated polypeptide antigen vaccine, preparation method therefor and appl2025
Attenuated salmonella synthesizing antigens for vaccinating against helicobacter2025
Immersion liquid cooling device and liquid cooling system2025
Immersed liquid cooling apparatus and liquid cooling system2025
Modular air cooling device and cooling system2025
Multiple lamp primer set, detection method, and kit for simultaneous detection o2024
Protective immunity enhanced Salmonella vaccine (PIESV) against Brucella spp2024
Live self-destructing bacterial adjuvants to enhance induction of immunity2024
Induction of protective immunity against antigens2023
Induction of protective immunity against antigens2023
Food safety vaccine to control Salmonella enterica and reduce Campylobacter in p2023
Food safety vaccine to control Salmonella enterica and reduce Campylobacter in p2023